The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer

Ovarian cancer is the most lethal gynecological malignancy, with an alarmingly poor prognosis attributed to late detection and chemoresistance. Initially, most tumors respond to chemotherapy but eventually relapse due to the development of drug resistance. Currently, there are no biological markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Brachova, Pavla, Thiel, Kristina W., Leslie, Kimberly K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794832/
https://www.ncbi.nlm.nih.gov/pubmed/24065105
http://dx.doi.org/10.3390/ijms140919257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794832/
https://www.ncbi.nlm.nih.gov/pubmed/24065105
http://dx.doi.org/10.3390/ijms140919257

Ejemplares similares